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Abstract
The restoration of body composition (BC) parameters is considered to be one of the most
important goals in the treatment of patients with anorexia nervosa (AN). However, little is
known about differences between AN diagnostic subtypes [restricting (AN-R) and binge/
purging (AN-BP)] and weekly changes in BC during refeeding treatment. Therefore, the
main objectives of our study were twofold: 1) to assess the changes in BC throughout nutri-
tional treatment in an AN sample and 2) to analyze predictors of BC changes during treat-
ment, as well as predictors of treatment outcome. The whole sample comprised 261
participants [118 adult females with AN (70 AN-R vs. 48 AN-BP), and 143 healthy controls].
BC was measured weekly during 15 weeks of day-hospital treatment using bioelectrical
impedance analysis (BIA). Assessment measures also included the Eating Disorders
Inventory-2, as well as a number of other clinical indices. Overall, the results showed that
AN-R and AN-BP patients statistically differed in all BC measures at admission. However,
no significant time×group interaction was found for almost all BC parameters. Significant
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time×group interactions were only found for basal metabolic rate (p = .041) and body mass
index (BMI) (p = .035). Multiple regression models showed that the best predictors of pre-
post changes in BC parameters (namely fat-free mass, muscular mass, total body water
and BMI) were the baseline values of BC parameters. Stepwise predictive logistic regres-
sions showed that only BMI and age were significantly associated with outcome, but not
with the percentage of body fat. In conclusion, these data suggest that although AN patients
tended to restore all BC parameters during nutritional treatment, only AN-BP patients
obtained the same fat mass values as healthy controls. Put succinctly, the best predictors of
changes in BC were baseline BC values, which did not, however, seem to influence treat-
ment outcome.
Introduction
Body composition (BC) is considered an accurate measurement of nutritional status and health
risk [1,2]. The main components of BC are fat mass (FM), total body water (TBW) and fat-free
mass (FFM) [composed of bone and muscle mass (MM)] [3]. The Food and Agriculture Orga-
nization of the United Nations (FAO) have reported that, among the general population of
women, 20–30% of the total body weight consists of FM [4], and the TBW in healthy adult
women accounts for 45%–60% of total body weight [5].
Anorexia nervosa (AN) is a mental disorder that results in extreme body weight loss and
high levels of malnutrition due to food restriction [6]. Because of low weight levels, it is not sur-
prising that patients with AN have been found to exhibit multiple metabolic disturbances and
a significant decrease in FM and FFM [7], as well as high levels of TBW [8]. Although both
NICE and APA treatment guidelines consider the recovery of body weight and the restoration
of BC to be one of the most important goals in the treatment of patients with AN, little research
has been carried out in this area. The scarce literature on this topic shows rates of FM recovery
ranging from 21% to 78% of the total weight gain [7,9–11]. Research in this field has already
described that initial weight increases during the refeeding phase is primarily due to increased
FM, as FFM increases occur more slowly over time [7,12]. Moreover, some studies have shown
that adult female patients with AN present a disproportionate increase of trunk fat after weight
gain, resulting in central adiposity [13–15]. However, it seems that this abnormal fat distribu-
tion normalizes with time as long as weight recovery is maintained [16]. Additionally, AN
patients increase TBW levels during the initial phases of nutritional therapy and this could lead
to edema as a consequence [17]. Patients with AN may also experience higher basal metabolic
rate (BMR) during refeeding treatment and usually need to eat more calories than healthy indi-
viduals to maintain the same healthy weight [18].
When considering AN subtypes, some differences have been found between binge/purging
(AN-BP) and restrictive (AN-R) subtypes. Whereas the former presents a greater percentage of
FM, the latter has been found to require greater caloric intake to achieve weight restoration
[19]. However, 3 to 6 months after achieving healthy weight, both groups tend to normalize
their metabolism to the same level as healthy controls [18]. Despite these BC differences, just
two studies have assessed AN-R and AN-BP separately [10,20], and these studies present sev-
eral shortcomings, such as lack of a control group or information about TBW or BMR.
The present study attempts to overcome some of the limitations of previous studies by
including a larger and more homogeneous sample of both AN-R and AN-BP patients who
were objectively assessed and monitored weekly throughout treatment and for a one-year
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follow-up. Furthermore, this is the first study, to our knowledge, that longitudinally investi-
gates the role of BC parameters as predictors of treatment outcome. We expect that the find-
ings of this study could provide useful information in the development of nutritional
guidelines and treatments for patients with AN by taking these two disorder subtypes into con-
sideration. Thus, the specific aims of the study were: 1) to assess the impact of diagnostic sub-
type on the nutritional status (i.e. BC and BMR) of AN patients; 2) to describe the changes of
BC distribution and BMR in a large sample of AN patients over time compared to a sample of
healthy controls; 3) to analyze clinical and psychological predictors of change in BC during




The final sample included 118 adult females with anorexia nervosa (70 AN-R and 48 AN-BP),
and 143 normal eating/weight controls without the history of an eating disorder (HC). Eating
disorder (ED) diagnosis was originally made according to DSM-IV-TR criteria [21] and deter-
mined by experienced psychologists and psychiatrists. These diagnoses were reanalyzed post
hoc using DSM-5 criteria [6]. The imbalance between the number of AN subtypes is due to the
fact that the sample consisted of patients who were consecutively admitted for assessment and
treatment at the Eating Disorders Unit (Department of Psychiatry, University Hospital of Bell-
vitge, Barcelona), between 2008 and 2012.
The AN-R sample had a mean age of 25.43 years (SD = 7.77) and a baseline body mass
index (BMI) of 16.71 (SD = 1.03). A majority of the patients were single (80.0%) and had com-
pleted high school (41.5%). Approximately 63.5% of the AN-R sample was employed. The
AN-BP sample had a mean age of 28.27 years (SD = 8.04) and a baseline BMI of 17.21
(SD = 1.36). 73.9% were single and slightly more than half of them had completed high school
(51.2%). 63.4% of the AN-BP sample was employed. The HC sample comprised women who
were visiting the hospital for routine blood tests and students who volunteered to take part in
the study. The mean age of the HC sample was 25.23 years (SD = 7.11) and had a mean baseline
BMI of 20.78 (SD = 1.98). Most of the HC sample was single (73.6%), had completed high
school (58.1%) and were employed (49.3%).
From our initial sample of 152 AN patients, the following groups of individuals were
excluded from the present analysis: a) patients with incomplete questionnaires (n = 23), b)
patients with endocrine disorders such as diabetes mellitus, diabetes insipidus and hypo- or
hyperthyroidism (n = 2) and c) males (n = 9) as the number of men with this diagnosis was too
small to make meaningful comparisons. The exclusion criteria for the healthy-eating control
group were: a) being male, b) being younger than 18, c) presenting a lifetime history of ED and
a BMI below 18.5 kg/m2 or higher than 25 kg/m2 (n = 17).
Assessment
- Eating Disorders Inventory-2 (EDI-2; [22]. This is a reliable and valid 91-item multidimen-
sional self-report questionnaire that assesses cognitive and behavioral characteristics in ED.
The EDI-2 retains the eight scales found in the EDI (drive for thinness, bulimia, body dissatis-
faction, ineffectiveness, perfectionism, interpersonal distrust, interoceptive awareness, and
maturity fears) and adds 27 new items to three scales: asceticism, impulse regulation, and social
insecurity. All of these scales are answered on a 6-point Likert scale, and provide standardized
subscale scores. It has been validated in a Spanish population [22] with a mean internal consis-
tency of 0.63 (coefficient alpha).
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Anthropometrics and body composition analysis
Height was measured by a stadiometer without participants wearing shoes.
- Tanita BC-420MA: Body composition was measured by bioelectrical impedance analysis
(BIA) (Tanita BC- 420MA, Tanita Corp. Tokyo, Japan). This leg-to-leg body composition ana-
lyzer is a simple, accurate, noninvasive and validated method for assessing BC [23] which pro-
vides a small alternating voltage of 90 μA (50/60Hz) via electrodes on metal foot plates. Body
weight as well as FM, FFM, MM, TBW, BMR and BMI were calculated for each patient. BC
estimates are derived from body fluids making use of proprietary equations based on resistance
index, weight, height, age and sex. The manufacturers have kept these equations confidential
and they have not been reported in the literature. BIA has been validated against dual-energy
X-ray absorptiometry (DEXA) measures and other reference methods [23]. The literature indi-
cates that utilizing BIA is not only efficacious for assessing BC parameters in ED, but also it
could be advantageous in the treatment of AN patients [24].
Procedure
All patients were evaluated and diagnosed at the ED Unit at the University Hospital of Bellvitge
by experienced psychologists and psychiatrists. Two face-to-face interviews were conducted:
the first interview provided information about current ED symptoms, antecedents and other
psychopathological data of interest, and the second interview comprised a psychometrical and
anthropometric assessment. Additional demographic information including education, occu-
pation, weight history, impulsive behaviors and other relevant clinical variables regarding the
eating disorder were obtained by a face-to-face, standardized, structured interview. The same
assessment was repeated at the end of the treatment and at a one-year follow-up.
The assessment of BC was obtained weekly, always on the same day of the week and at the
same time (between 9:00 a.m. and 9:30 a.m.), using the above-described BIA (Tanita BC-
420MA) and according to the principles previously described by Kyle et al. [3].
Treatment
Every patient with AN received the same day-hospital (DH) treatment that combined nutri-
tional, dietary and group cognitive-behavioral therapy (CBT) treatment for patients with AN.
This manualized treatment consisted of cognitive-behavioral techniques including stimulus
control therapy, exposure and response prevention, cognitive restructuring, problem solving
training, social skills, relaxation techniques and relapse prevention. Moreover, individuals
received family psychoeducation in a group setting. Patients attended the DH from 9 a.m. to 3
p.m., five days a week (Monday—Friday), for a period of 15 weeks. Food intake was monitored
twice during breakfast and lunch (the main food intake of the day).
As part of the DH treatment, weekly weight monitoring was carried out, along with an
assessment of eating behavior and cognitions using self-report measures. Patients were re-eval-
uated at the end of their treatment and categorized into four categories: “full remission”, “par-
tial remission”, “non-remission” and "dropout" (i.e. voluntary treatment discontinuation).
These categories were based on treatment outcomes according to DSM-5 criteria [6].
Nutritional treatment
The nutritional guidelines for patients in the DH are established by the Dietetics and Nutrition
Unit at the University Hospital of Bellvitge. Caloric requirement is determined according to a
basic diet of 2300 kcal/day corresponding to a balanced distribution of macro- and micronutri-
ents, 60% carbohydrate, 25–30% fat and 15% protein. All patients received a progressive diet
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split into four phases (starting at 1200 kcal/day initially, and increasing energy intake to 2300
kcal/day) to avoid refeeding syndrome.
Ethics Statement
The followed procedures were agreed upon and approved by the Ethics Committee of our insti-
tution (namely the Ethics Committee of Clinical Research at the University Hospital of Bell-
vitge) in accordance with the Helsinki Declaration of 1975 as revised in 1983. We obtained
signed informed consent from all participants (all patients were adults; no minors were
involved in this study).
Statistical analysis
Statistical analysis was carried out with SPSS20 for Windows (SPSS Inc). Analysis of variance
(ANOVA) procedures compared the mean of clinical variables between diagnostic subtypes
(AN-R, AN-BP and HC), defining post-hoc multiple contrasts through Bonferroni estimations
to measure pairwise comparisons. Pre-post differences (values taken at the start and at the end
of treatment) for BC measures were analyzed through a mixed-design ANOVA, defining time
(pre- and post-scores) as the intra-factor and group (AN-R and AN-BP) as the inter-factor.
Main effects for the time factor were estimated and interpreted in the case of significant time×-
group interactions and single effects were estimated-interpreted for non-significant time×-
group interactions.
Multiple regression models determined the main predictors of pre-post changes in BC mea-
sures in the AN sample. The ENTER procedure was defined to simultaneously include the fol-
lowing potential predictors: BC measures at baseline (i.e. the level of each BC parameter at
admission), patients’ age, duration of the ED, EDI-2 total score and AN-subtype (0 = restricting,
1 = binge/purging). The global predictive capacity of the models was measured using adjusted-
R2 coefficient.
Finally, logistic regressions assessed the main predictors of therapy outcomes, dropout and
remission. Stepwise procedures were defined to automatically select the best discriminative
variables, considering the following potential independent variables: BC measures at baseline,
patients’ age, duration of the ED, EDI-2 total score and AN-subtype (0 = restricting, 1 = binge/
purging). The global predictive capacity of the final models was measured using Nagelkerke’s-
R2 coefficient.
In cases of multiple comparisons, the Bonferroni correction method has been largely criti-
cized for being too conservative and no standard alternative procedure has been agreed upon.
From a practical-clinical perspective, effect sizes are the relevant objective of the analyses (p-
values are strongly dependent to sample sizes) and thusly, all the effect sizes for the relation-
ships analyzed in this study have been estimated to correct for the use of multiple group com-
parisons. For pairwise comparisons (in contrast with the ANOVA procedure), effect sizes were
measured through Cohen’s d coefficient [25] (|d|<0.5 was considered poor, |d|>0.5 was con-
sidered moderate and |d|>0.8 was considered large), with a 95% confidence interval (95%CI)
for mean differences (MD) and odds ratio (OR).
Results
Comparison between groups at baseline
Table 1 shows the distribution of the eating behavior and BC measures at baseline, and com-
parisons for the two diagnosis subtype conditions (AN-R and AN-BP) and HC. AN-BP
patients were found to significantly differ from HC participants in all variables, and most of
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the effect sizes of these differences were in the high range (|d|>0.80), with the sole exception of
perfectionism scale which was moderate (|d|0.50). AN-R patients also differed from controls
in all measures, except for the EDI-2 bulimia score, and the effect sizes of mean differences
were in the moderate to high range.
Pairwise comparisons between AN-R versus AN-BP subtypes found significant differences
for some EDI-2 scales (drive for thinness, body dissatisfaction, interoceptive awareness,
bulimia, asceticism and total score), with AN-BP patients obtaining higher EDI-2 scores. Effect
sizes for mean differences were in the moderate to high range for EDI-2 drive for thinness,
bulimia and asceticism scores. All BC means were also statistically different when comparing
AN-R and AN-BP subtypes. AN-BP patients had significantly higher FM and BMI than AN-R
patients, though AN-R patients obtained higher mean values in all the remaining BC measures.
Changes in body composition during treatment
Fig 1 shows the evolution of main BC means for AN patients during therapy and at the
12-month follow-up. The incorporation of polynomial contrasts into the ANOVA procedures
Table 1. Clinical comparisons between anorexia nervosa subtypes and healthy controls.
Means ANOVA
AN-R AN-BP HC Group AN-BP vs AN-R AN-R vs HC AN-BP vs HC
N = 70 N = 48 N = 143 p MD | d | MD | d | MD | d |
Age of onset (years-old) 18.27 20.43 — .169 2.16 0.292
Duration of the ED (years) 6.56 7.87 — .372 1.31 0.190
EDI: Drive for thinness 10.95 15.63 2.50 < .001 4.69* 0.731† 8.45* 1.413† 13.13* 2.727†
EDI: Body dissatisfaction 11.56 14.98 5.10 < .001 3.41* 0.428 6.46* 0.925† 9.88* 1.364†
EDI: Interocep. awareness 8.47 10.63 1.53 < .001 2.16* 0.380 6.94* 1.441† 9.11* 2.286†
EDI: Bulimia 1.47 5.10 0.63 < .001 3.62* 1.056† 0.84 0.439 4.47* 1.359†
EDI: Interpersonal distrust 5.58 5.24 1.83 < .001 -0.34 0.076 3.75* 1.049† 3.42* 0.912†
EDI: Ineffectiveness 9.20 9.78 1.49 < .001 0.58 0.076 7.71* 1.306† 8.29* 1.531†
EDI: Maturity fears 7.62 7.59 3.57 < .001 -0.03 0.006 4.05* 0.870† 4.01* 0.926†
EDI: Perfectionism 6.22 5.76 3.60 < .001 -0.46 0.093 2.62* 0.621† 2.16* 0.529†
EDI: Impulse regulation 5.49 5.97 1.11 < .001 0.48 0.088 4.38* 0.980† 4.86* 1.223†
EDI: Asceticism 5.58 8.05 1.89 < .001 2.47* 0.573† 3.70* 1.095† 6.17* 1.852†
EDI: Social insecurity 6.65 6.85 1.86 < .001 0.19 0.041 4.80* 1.230† 4.99* 1.358†
EDI: Total score 78.80 95.38 25.11 < .001 16.58* 0.398 53.69* 1.564† 70.28* 2.303†
FM%-baseline 8.42 10.50 15.30 < .001 2.08* 0.390 -6.88* 1.367† -4.80* 0.920†
FFM (kg)-baseline 40.64 39.38 42.95 < .001 -1.26* 0.395 -2.31* 0.658† -3.57* 1.009†
MM (kg)-baseline 38.57 37.36 40.76 < .001 -1.21* 0.396 -2.20* 0.658† -3.40* 1.011†
TBW%-baseline 63.66 61.64 54.77 < .001 -2.03* 0.431 8.89* 2.050† 6.86* 1.615†
Bone-baseline 2.08 2.01 2.19 < .001 -0.06* 0.409 -0.11* 0.653† -0.18* 0.990†
BMR-baseline 1224.9 1184.1 1325.1 < .001 -40.77* 0.438 -100.2* 0.995† -141.0* 1.360†
BMI -baseline 16.71 17.21 20.78 < .001 0.50* 0.413 -4.07* 2.581† -3.57* 2.101†
MD: mean difference. d: Cohen’s-d measuring effect size for mean difference.
*Signiﬁcant mean difference (pairwise comparison, contrast) (.05 level).
†Moderate (|d|0.50) to large (|d|0.80) effect size.
—Measure not available for the HC group.
AN-R: anorexia nervosa restricting subtype. AN-BP: anorexia nervosa binge/purging subtype. BMI: body mass index. BMR: basal metabolic rate. ED:
eating disorder. FFM: fat-free mass. FM: fat-mass. HC: healthy controls. MM: muscular mass. TBW: total body water.
doi:10.1371/journal.pone.0143012.t001
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showed a significant linear trend for all these measures, indicating an increase in FM, FFM and
MM, and a decrease in TBW. The presence of other significant trends during the process
showed that changes were not statistically constant during therapy and follow-up. As seen in
Fig 1, FM increased regularly and progressively during every week of treatment, whereas FFM
Fig 1. Evolution in body composition in AN patients during treatment. Horizontal dashed-line represents the linear trend and vertical dashed-line
indicates a significant change in the slope-trend.
doi:10.1371/journal.pone.0143012.g001
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and MM showed a sharp increase during the first 7 weeks of treatment, but stabilized at mid-
treatment.
Table 2 shows the means for the BC measures at baseline and at the end of treatment, and
the comparison of the pre-post mean changes. No significant time×group interaction was
obtained for FM, FFM, MM, TBW and bone mass, indicating that mean changes were statisti-
cally equal for both diagnostic conditions (AN-R and AN-BP). A significant mean increase was
observed for this set of variables at the end of therapy, with the exception of total body water,
which registered a significant mean decrease. As per BMR and BMI, a time×group significance
was obtained, indicating that pre-post mean changes were different for the two diagnostic con-
ditions: this pre-post mean increase was higher for binge/purging subtype compared to restrict-
ing subtype. Effect sizes for the mean changes shown in Table 2 were only in the moderate to
high range for FM, TBW, BMR and BMI.
Table 3 shows the means for BC measures at the end of treatment for the AN groups and
the means for the HC group. Pairwise comparison between AN-R and HC showed significant
differences in all BC measures (effect sizes were moderate to high for FM, TBW, BMR and
BMI), with the AN-R sample presenting lower FM, BMR, BMI and higher TBW than the HC
group. Comparing AN-BP to HC conditions, all BC means significantly differed (with the
exception of FM): AN-BP patients, at the end of the treatment, still had lower FFM, MM, bone
mass, BMR and BMI values and higher TBW than the HC sample (effect sizes for significant
mean differences were moderate to high). Post-hoc comparisons for AN-BP and AN-R only
obtained significant results for FM (higher for binge/purging subtype), total body water (higher
for restricting subtype) and BMI (higher for binge/purging patients). Effect sizes for these three
statistical differences were in the moderate range.
S1 Fig (see “Supporting Information”) shows the evolution of BC means for AN patients at
pre-treatment, post-treatment and one-year follow-up, and the comparison with the HC
group.
Table 2. Changes in body composition for AN patients.
Mean Inter. Factor: Time (difference pre-post)
AN-R (N = 70) AN-BP (N = 48) time×gr. Sign. Mean 95%CI Cohen’s
Pre Post Pre Post p p differ. Mean difference | d |
FM% 8.22 11.86 10.15 15.03 .119 < .001 4.26* 3.47; 5.04 0.689†
FFM (kg) 40.68 41.42 39.39 40.82 .081 < .001 1.09* 0.70; 1.47 0.344
MM (kg) 38.60 39.31 37.37 38.74 .076 < .001 1.04* 0.67; 1.41 0.345
TBW% 63.51 60.74 61.71 58.30 .259 < .001 -3.09* -3.65; -2.53 0.598†
Bone 2.08 2.11 2.01 2.08 .178 < .001 0.05* 0.03; 0.07 0.336
BMR 1224.5 1249.8 1182.6 1229.6 .041 < .001R 25.30*R 12.24R; 38.36R 0.273
< .001P 47.02*P 30.84P; 63.21P 0.506†
BMI 16.71 17.69 17.21 18.62 .035 < .001R 0.98*R 0.72R; 1.23R 0.806†
< .001P 1.41*P 1.10P; 1.72P 0.973†
*Signiﬁcant mean difference (pairwise comparison, contrast) (.05 level).
†Moderate (|d|0.50) to large (|d|0.80) effect size.
RPre-post (at the start and at the end of treatment) comparison for AN- restricting.
PPre-post comparison for AN-binge/purging.
AN-R: anorexia nervosa restricting subtype. AN-BP: anorexia nervosa binge/purging subtype. BMI: body mass index. BMR: basal metabolic rate. FFM:
fat-free mass. FM: fat mass. MM: muscular mass. TBW: total body water.
doi:10.1371/journal.pone.0143012.t002
Body Composition in AN
PLOSONE | DOI:10.1371/journal.pone.0143012 November 23, 2015 8 / 15
Predictors of changes in body composition
Table 4 shows the results of multiple regression models assessing what the best predictors of
pre-post changes (from the start to the end of therapy) in BC were. These models included BC
measures at baseline, for example the model for FM change included the FM value at the
moment of admission. No significant predictors emerged for FM and BMR. For FFM, MM,
TBW and BMI, the only significant predictors of pre-post changes were these same BC mea-
sures at baseline.
Body composition as a predictor of treatment outcome and dropout rates
No statistical differences due to AN subtype were found for the risk of dropout, total, partial or
non-remission in the AN group (χ2 = 4.595, df = 3, p = .204). Most of the AN-R sample pre-
sented full (40%) or partial remission (15.7%), while 20% showed non-remission. Similarly, in
the AN-BP sample, 43.8% presented full remission, 27.1% partial remission and 8.3% non-
remission. Dropout rates were similar between AN-R (24.3%) and AN-BP patients (20.8%).
Table 5 shows the stepwise predictive logistic regressions for therapy outcome. This model
contains the best predictors (statistically significant independent variables) of dropout and
remission (full or partial+full) during therapy, while also considering the patients’ baseline
state. No BC parameter emerged as a predictor of treatment outcome. The best predictor of
dropout during therapy was age, (the younger the AN patient, the higher the risk of dropout).
BMI was the best discriminative variable of "full remission" outcome (the higher BMI at base-
line, the higher the probability of full remission). The probability of partial or full remission
was higher for patients who were older and had high BMI.
Discussion
The first main finding of the present study was that both AN-R and AN-BP patients showed
altered BC compared to healthy controls, which is consistent with the findings of other authors
[7,10,11,14]. Furthermore, AN-R and AN-BP patients showed differences in all the BC param-
eters measured. In line with a prior study [20], AN-R patients had a lower percentage of FM
Table 3. Comparisons between body composition at the end of treatment in AN patients and controls.
Mean ANOVA
AN-R AN-BP HC Group AN-R vs AN-BP AN-R vs HC AN-BP vs HC
N = 70 N = 48 N = 143 p MD | d | MD | d | MD | d |
FM% 11.86 15.03 15.30 < .001 3.18* 0.583† 3.45* 0.661† 0.27 0.052
FFM (kg) 41.42 40.82 42.95 < .001 -0.60 0.209 1.53* 0.435 2.13* 0.659†
MM (kg) 39.31 38.74 40.76 < .001 -0.56 0.206 1.46* 0.436 2.02* 0.657†
TBW% 60.74 58.30 54.77 < .001 -2.52* 0.590† -6.25* 1.434† -3.73* 0.999†
Bone 2.11 2.08 2.19 < .001 -0.04 0.257 0.07* 0.420 0.11* 0.689†
BMR 1249.8 1229.6 1325.0 < .001 -20.37 0.230 75.10* 0.731† 95.46* 0.977†
BMI 17.69 18.62 20.78 < .001 0.93* 0.643† 3.09* 1.819† 2.16* 1.224†
MD: mean difference. d: Cohen’s-d measuring effect size for mean difference.
*Signiﬁcant mean difference (pairwise comparison, contrast) (.05 level).
†Moderate (|d|0.50) to large (|d|0.80) effect size.
AN-R: Anorexia nervosa restricting. AN-BP: Anorexia nervosa binge/purging. BMI: body mass index. BMR: basal metabolic rate. FFM: fat-free mass. FM:
fat mass. HC: healthy controls. MM: muscular mass. TBW: total body water.
doi:10.1371/journal.pone.0143012.t003
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than AN-BP, but a greater percentage of FFM, MM and TBW. This could be explained by the
high levels of physical activity found among those with AN-R [26]. Patients with compulsive
exercising have a lower frequency of binge eating, vomiting, and laxative abuse than non-exer-
cisers [27], and the fact that AN-BP patients have more prevalence of binge eating episodes
may also explain why these patients had more FM than restrictive ones.
Table 4. Predictors of pre-post changes in body composition for AN patients.
Fat mass (adjusted R2 = .051) Fat-free mass (adjusted R2 = .037)
B SE Beta p 95%CI(B) B SE Beta p 95%CI(B)
Intercept 7.706 1.973 — < .001 3.755 11.657 5.367 2.423 — .030 0.534 10.201
BC-baseline -.053 0.080 -.086 .512 -0.213 0.107 -.114 0.055 -.256 .042 -0.224 -0.004
Age (years-old) -.090 0.064 -.226 .165 -0.218 0.038 .026 0.024 .159 .281 -0.022 0.075
Duration ED (years) -.068 0.074 -.145 .361 -0.216 0.080 -.032 0.026 -.174 .220 -0.083 0.019
EDI-total score -.006 0.010 -.076 .579 -0.026 0.014 .005 0.004 .178 .161 -0.002 0.013
AN-subtype (purging) 1.20 0.930 .182 .204 -0.668 3.057 -.098 0.341 -.036 .775 -0.777 0.582
Muscular mass (adjusted R2 = .035) Total body water (adjusted R2 = .028)
B SE Beta p 95%CI(B) B SE Beta p 95%CI(B)
Intercept 5.060 2.299 — .031 0.474 9.646 -13.03 3.774 — .001 -20.56 -5.500
BC-baseline -.113 0.055 -.253 .045 -0.222 -0.003 .255 0.055 .507 < .001 0.146 0.364
Age (years-old) .025 0.023 .158 .284 -0.021 0.071 .006 0.041 .019 .884 -0.075 0.087
Duration ED (years) -.030 0.024 -.174 .221 -0.079 0.019 -.007 0.043 -.022 .865 -0.093 0.079
EDI-total score .005 0.004 .170 .180 -0.002 0.012 -.002 0.006 -.041 .720 -0.015 0.010
AN-subtype (purging) -.085 0.324 -.033 .794 -0.731 0.562 .672 0.562 .135 .236 -0.449 1.793
Basal metabolic rate (adjusted R2 = .046) Body mass index (adjusted R2 = .036)
B SE Beta p 95%CI(B) B SE Beta p 95%CI(B)
Intercept 177.6 83.37 — .037 11.2 343.9 3.840 1.467 — .011 0.920 6.760
BC-baseline -.119 0.060 -.274 .052 -0.239 0.001 -.179 0.083 -.241 .034 -0.344 -0.014
Age (years-old) .615 0.770 .125 .427 -0.921 2.151 .019 0.016 .159 .227 -0.012 0.050
Duration ED (years) -1.127 0.751 -.210 .138 -2.624 0.371 -.020 0.017 -.151 .238 -0.054 0.014
EDI-total score .065 0.113 .072 .565 -0.160 0.290 .000 0.002 .021 .857 -0.004 0.005
AN-subtype (purging) 1.16 9.948 .015 .907 -18.681 21.008 .007 0.213 .004 .976 -0.417 0.430
Multiple regression models (ENTER procedure). Bold: signiﬁcant parameter. BC measures: measure of each body composition parameter at admission.
ED: eating disorder.
doi:10.1371/journal.pone.0143012.t004
Table 5. Significant predictors of treatment outcome for AN patients.
Criterion (outcome) Predictors B SE Wald(1) p OR 95%CI (OR)
Dropout Intercept 0.676 0.853 0.628 0.428 1.966 — —
(Nag-R2 = .071) Age (years-old) -0.075 0.034 4.814 .028 0.928 0.868 0.992
Full remission Intercept -9.005 3.121 8.322 .004 .000 — —
(Nag-R2 = .098) BMI at baseline 0.510 0.183 7.802 .005 1.665 1.164 2.381
Partial or Full remission Intercept -11.056 3.275 11.394 .001 .000 — —
(Nag-R2 = .171) Age (years-old) 0.064 0.028 5.437 .020 1.068 1.010 1.126
BMI at baseline 0.585 0.181 10.429 .001 1.796 1.259 2.562
Logistic regression models (STEPWISE procedure). Nag-R2: Nagelkerke’s-pseudo-R2. BMI: body mass index.
doi:10.1371/journal.pone.0143012.t005
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Also, AN-R patients showed higher BMR than AN-BP. This is in line with other authors
[19] reporting that AN-R requires higher caloric intake than AN-BP to maintain a stable
weight. Accordingly, a previous study revealed that a history of bulimic symptoms in AN
patients may lead to lower caloric requirements [28]. Thus, these data highlight the differences
in energy-metabolism efficiency between diagnostic subtypes.
Body composition changes and weight recovery in AN
Our hypothesis that BC in AN patients would be normalized after the refeeding treatment was
partially supported by the present findings. Changes in all BC parameters were observed
throughout the nutritional therapy, but only patients with AN-BP reached the same percentage
of FM as the control group after treatment, which may be an integral part of recovery. How-
ever, all the BC parameters obtained after therapy were close to published 50 percentile values
in healthy women [4]. These changes were large for FM, FFM and TBW, and were maintained
after one-year follow-up. Otherwise, all the differences between AN-BP and AN-R patients at
admission were non-existent at the end of treatment, with the exceptions of FM, BMI and
TBW. Furthermore, we observed an interaction between the magnitude of the change in BMR
and diagnostic subtype, with BMR increases in AN-BP patients being greater than in AN-R
patients. This may be due to AN-BP patients presenting lower BMR at admission than restrict-
ing patients. Contrary to a previous study [18], our results did not show that AN patients
became hypermetabolic during re-nutrition treatment. Similarly, Bossu et al [29] found that
constitutionally lean women (without AN) presented lower BMR than normal-weight women,
suggesting an adaptive role for BMR.
An intriguing finding was that FM constantly and progressively increased during every
week of treatment, while FFM and the MM showed a rapid increase during the first 7 weeks of
treatment, but stabilized at mid-treatment. These results are consistent with a prior study indi-
cating that, in patients with a very low BMI and an initial FM of 4 kg, FFM initially increases
more than FM [30]. However, our results are not consistent with other authors [7,12] indicat-
ing a greater initial increase of FM and only a progressive, minor gain of FFM during the same
period of treatment. These discrepancies might be due to differences in the malnourished state
of patients at admission, as proposed Yamashita et al. [30]. Regarding body water, our results
failed to find an increase in TBW during the first weeks of refeeding, as Krahn et al [17]
reported. In contrast, our results showed that following the second week of nutritional therapy,
TBW levels decreased progressively. Overall, the present study has the strength that it is the
first to consecutively measure the BC of a large sample of adult AN patients on a weekly basis,
unlike in other studies in which BC assessment is performed, at most, at four points during the
whole course of treatment.
Body composition as a predictor of changes in psychopathology
In terms of BC improvement (measured through pre–post differences), we found that the base-
line values of BC parameters were the best predictors of change for most of the anthropometric
parameters. In this sense, presenting lower levels of FFM, MM and BMI and higher TBW at
baseline were associated with greater positive changes in these parameters. However, contrary
to previous studies [2,31], our results did not find associations between clinical variables, such
as age or duration of the disorder, and changes in BC. These discrepancies could be due to the
fact that most differences were found comparing adolescents to adults, but in our case, all the
participants were adults with AN. Finally, our findings were not able to uncover a positive asso-
ciation between eating disorder psychopathology and changes in BC. These results are in
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agreement with those published by El Ghoch et al. [15], who suggested that changes in BC
were not associated with distress, body image or eating disorder psychopathology.
Body composition as a predictor of treatment outcome and dropout rates
Treatment outcome for AN-R patients was similar overall to AN-BP patients. In terms of pre-
dictors, our findings suggest that higher BMI as well as older age were positively associated
with better treatment outcomes. Accordingly, a low BMI at the beginning of treatment has
been identified as one of the most important risk factors for poor prognosis in AN [32]. How-
ever, contrary to our hypothesis, our findings were not able to uncover a direct association
between low FM and poor clinical outcome in AN patients [18]. One possible explanation may
be that low FM is a predictor of poor prognosis only when the patients are very severe and
present extremely low values of FM. In our sample, patients were in DH treatment and there-
fore, they were less severely affected by the disorder and less resistant to treatment than indi-
viduals receiving in-patient treatment.
The present study should be evaluated within the context of several limitations. First, we
only included adult female AN patients from Spain. Hence, we do not know whether our
results are generalizable to adolescent ED patients, males or individuals from other ethnic
backgrounds. Second, the BC analyzer we used does not enable the measurement of regional
BC and thus does not allow us to assess whether our sample presented central adiposity after
refeeding treatment. Finally, the present study failed to consider hormones strongly related to
metabolism (mainly leptin) and FM. Since a positive correlation between leptin levels and FM
has been well-documented [33], and an association between a lower presence of leptin in AN
patients with disease duration has been found [34], finding hormonal changes, such as an
increase in leptin being associated with FM recovery, could be expected. It would be of interest
to study these associations in order to elucidate the specific role of these hormones in the tim-
ing of body composition restoration. Therefore, future studies should aim to collect this infor-
mation and to replicate this study while assessing hormones and using a segmental BC
analyzer to assess adiposity distribution.
In spite of these limitations, the current study also features several strengths. This study has
addressed, for the first time, the BC of both AN-R and AN-BP patients using weekly monitor-
ing and a one-year follow-up. The second strength is the availability of a large sample of
healthy controls for comparison. Furthermore, this is the first study assessing BC predictors of
outcome, and analyzing predictors of change in BC compartments during refeeding treatment,
which, to our knowledge, has not been attempted before.
The findings from the present study may help to shape appropriate nutritional guidelines
and treatment programs for patients with AN. As the review by Saladino [24] suggests, the
assessment of BC changes during the treatment of AN patients might allow for the develop-
ment of individualized nutritional diets for each patient. Even though our results showed dif-
ferences between AN-R and AN-BP in BC distribution at admission, it seems that both AN-R
and AN-BP patients would benefit equally from the same nutritional treatment. Given the high
mortality rate found in AN [35], it is imperative to study BC to develop nutritional guidelines
and cost-effective methods of treatment.
Conclusions
In conclusion, our findings confirm the progressive improvement in all BC parameters in adult
AN patients during DH nutritional treatment. Both AN-R and AN-BP patients showed differ-
ences in BC distribution at admission, but these differences do not appear to influence BC
recovery, with the exception of BMR. It is also noteworthy that the best predictors of BC
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changes were baseline BC values. Curiously, no BC parameter was found to be a predictor of
outcome, only higher baseline BMI and older age were associated with better treatment out-
comes and lower risk of dropout.
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